Table IV.
Results of statistical analysis.
| Factor | PR+SD | PD | P-value |
|---|---|---|---|
| Age, years | 63.6 | 63.3 | 0.953 |
| Stage | 0.737 | ||
| 1 | 0 | 1 | |
| 2 | 3 | 1 | |
| 3 | 1 | 1 | |
| 4 | 2 | 1 | |
| Total mEHT, n | 31.6 | 74.0 | 0.006 |
| mEHT/w, n | 2.0 | 2.5 | 0.312 |
| mEHT period, weeks | 14.8 | 30.2 | 0.002 |
| mEHT dose, kJ | 11,843 | 27,676 | 0.002 |
| Pre-treat, total | 3.5 | 6.0 | 0.199 |
| Pre-CT, n | 1.8 | 2.5 | 0.689 |
| Pre-CEA, ng/ml | 5.51 | 141.5 | 0.017 |
| Post-CEA, ng/ml | 3.85 | 285.6 | 0.009 |
Total mEHT, total number of mEHT; mEHT/w, number of mEHT per week; mEHT period, periods of mEHT (weeks); mEHT dose, total doses of mEHT (kj); pre-treat, number of treatments before mEHT; pre-CT, number of chemotherapies before mEHT; pre-CEA, CEA before of mEHT; post-CEA, CEA after mEHT; PR, partial remission; SD, stable disease; PD, progressive disease; mEHT, modulated electro-hyperthermia.